Assurgen Pharma Private Limited - Company Profile

It is a pharma private limited company based in Visakhapatnam, Andhra Pradesh, India, established in 2013.
2013 Visakhapatnam, Andhra Pradesh, India Active
Last Updated:
Access Report
About Assurgen Pharma Private Limited

Assurgen Pharma Private Limited, a active private limited company, was established on 10 October 2013 in Visakhapatnam, Andhra Pradesh, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24232AP2013PTC090442. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹80.00 Cr and a paid-up capital of ₹75.46 Cr.

It upholds a compliant status. Employing 135 professional, Its leadership includes Naveen Parupalli (Director), Paidi Lakshman Rao (Director), Srinivasa Rao Vayetla (Director). Past directors included Srinivasarao Venkatanaga Divvela, Paidi Lakshman Rao, Chivukula Mahalakshmi. It holds ₹23.50 Cr open charges and ₹23.29 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.23E, Lalamkoduru Village, Rambilli Mandal,Apsez Denotified Area,At, Chutapuram, Visakhapatnam, Andhra Pradesh, 531011.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232AP2013PTC090442

  • Registration Number

    090442

  • Incorporation Date

    10 October 2013

  • Authorized Capital

    ₹80.00 Cr

  • Paid-Up Capital

    ₹75.46 Cr

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 80.00 Cr
  • Paid Up Capital ₹ 75.46 Cr
  • Company Age 12 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 23.50 Cr
  • Satisfied Charges ₹ 23.29 Cr
  • Revenue Growth **** 24.12%
  • Profit Growth **** 25.97%
  • Ebitda **** -22.06%
  • Net Worth -40.83%
  • Total Assets **** 12.83%
Company report

Assurgen Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Assurgen Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Assurgen Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Naveen Parupalli Director 10 Oct 2013 Current
Paidi Lakshman Rao Director 15 Nov 2014 Current
Srinivasa Rao Vayetla Director 30 Nov 2017 Current
Johann Danklmaier Director 02 Jul 2024 Current
Ravi Kumar Potluri Director 20 Dec 2016 Current
Nagendra Rao Kukalakunta Managing Director 10 Oct 2013 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 20 Dec 2016 Past
Pramod Abcsdd Director 30 Mar 2024 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Additional Director 29 Sep 2018 Past
Pramod Abcsdd Director 03 Jan 2018 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Assurgen Pharma.

Assurgen Pharma Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 24.12% increase. The company also saw a substantial improvement in profitability, with a 25.97% increase in profit. The company's net worth observed a substantial decline by a decrease of 40.83%.

Assurgen Pharma revenue growth over time
Assurgen Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 24.12%
*******
*******
*******
*******
Revenue from Operations
*******
 23.37%
*******
*******
*******
*******
Total Assets
*******
 12.83%
*******
*******
*******
*******
Profit or Loss
*******
 25.97%
*******
*******
*******
*******
Net Worth
*******
 -40.83%
*******
*******
*******
*******
EBITDA
*******
 -22.06%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Assurgen Pharma?

In 2023, Assurgen Pharma had a promoter holding of 90.91% and a public holding of 9.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹234,989,131.00

Satisfied Charges

₹232,900,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 23.50 Cr
Latest Charge Details
Date Lender Amount Status
30 Oct 2021 Hdfc Bank Limited ₹23.50 Cr Open
28 Jan 2019 Others ₹8.00 M Satisfied
05 Aug 2017 Others ₹4.00 Cr Satisfied
27 Mar 2017 Others ₹2.49 Cr Satisfied
24 Nov 2015 Andhra Pradesh State Financial Corporation. ₹16.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Assurgen Pharma?

Assurgen Pharma has a workforce of 135 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Assurgen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Assurgen Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Assurgen Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Assurgen Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Director Appointment

    Progress on Srinivas Nimmagadda was appointed as a Company Secretary was appointed as a Company Secretary on 12 Sep 2024 & has been associated with this company since 1 year 5 months . was documented.

  • Director Appointment

    Progress on Johann Danklmaier was appointed as a Director was appointed as a Director on 02 Jul 2024 & has been associated with this company since 1 year 7 months . was documented.

  • Balance Sheet

    Assurgen Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada. was recorded as a recent event.

  • Charges

    Progress on A charge with Hdfc Bank Limited of Rs. 23.50 Cr registered on 30 Oct 2021 with Charge ID 100514026 was modified on 26 Oct 2022. was documented.

  • Director Appointment

    Progress on Ishak Ali Mohammed was appointed as a Company Secretary was appointed as a Company Secretary on 17 Mar 2022 & has been associated with this company since 3 years 11 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Assurgen Pharma Private Limited?

The CIN of Assurgen Pharma Private Limited is U24232AP2013PTC090442.

Where is Assurgen Pharma Private Limited headquartered?

Assurgen Pharma Private Limited is headquartered at Plot No.23E, Lalamkoduru Village, Rambilli Mandal,Apsez Denotified Area,At, Chutapuram, Visakhapatnam, Andhra Pradesh, 531011.

When was Assurgen Pharma Private Limited incorporated?

Assurgen Pharma Private Limited was incorporated on 10 October 2013.

Who are the current directors of Assurgen Pharma Private Limited?

The current directors of Assurgen Pharma Private Limited are

What is the primary industry of Assurgen Pharma Private Limited?

The primary industry of Assurgen Pharma Private Limited is Manufacturing.

Is Assurgen Pharma Private Limited a listed company?

Assurgen Pharma Private Limited is unlisted.

What is the capital structure of Assurgen Pharma Private Limited?

The authorized capital of Assurgen Pharma Private Limited is ₹80.00 Cr, and the paid-up capital is ₹75.46 Cr.

What is the compliance status of Assurgen Pharma Private Limited?

The compliance status of Assurgen Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available